Validated PET-CT metabolic tumor volume threshold identifies high-risk relapsed/refractory LBCL and predicts 12-month toxicity-free progression-free survival Post–CAR-T therapy
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Masooma Rana, Nima Ghalehsari, Alexandria Jensen, Dasom (Caroline) Lee, Natalie Park, Anmol Goyal, Ayesha Hashmi, William Wang, Eric Heng, Arash Velayati, Gaurav Dhapola, Ying-Wen Huang, Bita Sahaf, Wen-Kai Weng, Surbhi Sidana, Melody Smith, Sushma Bharadwaj, Matthew Frank, David Miklos, Michael Binkley, Saurabh Dahiya
Institutions: Stanford University, Cleveland Clinic
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417006919
Cites:
Cited by:
Related to: